Clinical Trials

161 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Clear all
NCT06761677 2026-02-05

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

SymBio Pharmaceuticals

Phase 1/2 Suspended
43 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Epstein-Barr Virus Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07358910 2026-01-22

RACSMEI

Institut Pasteur du Cambodge

Recruiting
10,000 enrolled
Classical hematology

Zika Virus Infection, Vaccine-Preventable Diseases, Vector Borne Diseases, Severe Fever with Thrombocytopenia Syndrome, Adenoviridae Infections, Arenaviridae Infections, Brucellosis, Bunyaviridae Infections, Chickenpox, Chlamydia Infections, Communicable Diseases, Dengue, Elephantiasis, Filarial, Encephalitis, Japanese, Encephalitis, Tick-Borne, Enterovirus Infections, Giardiasis, Hepatitis A, Leishmaniasis, Leptospirosis, Malaria, Measles, Melioidosis, Meningitis, Mumps, Mycoplasma Infections, Parvoviridae Infections, Q Fever, Rift Valley Fever, Rotavirus Infections, Rubella, Schistosomiasis, Tetanus, Trichuriasis, Whooping Cough, Yellow Fever, Zoonoses, Hepatitis E, Caliciviridae Infections, Hantavirus Infections, Epstein-Barr Virus Infections, Henipavirus Infections, Neglected Diseases, Chikungunya Fever

NCT02422875 2025-09-30

Comparative Autoantibody and Immunologic Cell Marker Study

Emory University

Enrolling by invitation
2,500 enrolled

Undifferentiated Connective Tissue Diseases, Immunoglobulin G4-Related Disease, Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, Autoimmune Diseases, Communicable Diseases, Graft vs Host Disease, Hepatitis C, Lupus Erythematosus, Systemic, Myositis, Sjogren's Syndrome, Purpura, Thrombocytopenic, Idiopathic, Sepsis, Epstein-Barr Virus Infections, Guillain-Barre Syndrome, Scleroderma, Diffuse, Autoimmune Lymphoproliferative Syndrome

NCT05592626 2025-07-09

START-001

Marengo Therapeutics, Inc.

Phase 1/2 Recruiting
365 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Abdominal Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms, Urogenital Neoplasms, Vulvar Diseases, Vulvar Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Epstein-Barr Virus Infections, Papillomavirus Infections, Microsatellite Instability, Small Cell Lung Carcinoma